Consensus Interferon and Ribavirin in Patients with Chronic Hepatitis C Who Were Nonresponders to Pegylated Interferon alfa-2b and Ribavirin

被引：0
|
作者：
Carroll B. Leevy
机构：
[1] University of Medicine & Dentistry of New Jersey,Department of Medicine, Division of Gastroenterology/Hepatology
[2] New Jersey Medical School Liver Center,undefined
来源：
Digestive Diseases and Sciences | 2008年 / 53卷 / 7期
关键词：
D O I：
10.1007/s10620-008-0252-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2009 / 2009
相关论文
共 50 条
  • [1] Consensus Interferon and Ribavirin in Patients with Chronic Hepatitis C Who Were Nonresponders to Pegylated Interferon alfa-2b and Ribavirin
    Carroll B. Leevy
    Digestive Diseases and Sciences, 2008, 53 : 1961 - 1966
  • [2] Consensus interferon and ribavirin in patients with chronic hepatitis c who were nonresponders to pegylated interferon alfa-2b and ribavirin
    Leevy, Carroll B.
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (07) : 1961 - 1966
  • [3] Consensus interferon and ribavirin in patients with chronic hepatitis C who were nonresponders to prior therapy with either interferon alfa and ribavirin or pegylated interferon and ribavirin
    Chen, K
    Seraphin, P
    Murphy, L
    Shah, N
    HEPATOLOGY, 2005, 42 (04) : 670A - 670A
  • [4] Pegylated interferon alfa 2b and ribavirin for hepatitis C patients who were nonresponders to previous
    Lawitz, EJ
    Bala, NS
    Becker, S
    Brown, G
    Davis, M
    Dhar, R
    Ganeshappa, KP
    Gordon, S
    Holtzmuller, K
    Jeffries, M
    Li, JJ
    Monsour, H
    Nader, P
    Rosenfield, T
    Tolman, K
    Kadakia, S
    GASTROENTEROLOGY, 2003, 124 (04) : A783 - A784
  • [5] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    PN Rao
    Abraham Koshy
    Jacob Philip
    Narayanan Premaletha
    Joy Varghese
    Krishnasamy Narayanasamy
    Samir Mohindra
    Nitin Vikas Pai
    Manoj Kumar Agarwal
    Ashokna Konar
    Hasmukh B Vora
    World Journal of Hepatology, 2014, (07) : 520 - 526
  • [6] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    Rao, P. N.
    Koshy, Abraham
    Philip, Jacob
    Premaletha, Narayanan
    Varghese, Joy
    Narayanasamy, Krishnasamy
    Mohindra, Samir
    Pai, Nitin Vikas
    Agarwal, Manoj Kumar
    Konar, Ashoknanda
    Vora, Hasmukh B.
    WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (07) : 520 - 526
  • [7] Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C
    Poynard, T
    McHutchison, J
    Manns, M
    Trepo, C
    Lindsay, K
    Goodman, Z
    Ling, MH
    Albrecht, J
    GASTROENTEROLOGY, 2002, 122 (05) : 1303 - 1313
  • [8] Merimepodib, Pegylated Interferon, and Ribavirin in Genotype 1 Chronic Hepatitis C Pegylated Interferon and Ribavirin Nonresponders
    Rustgi, Vinod K.
    Lee, William M.
    Lawitz, Eric
    Gordon, Stuart C.
    Afdhal, Nezam
    Poordad, Fred
    Bonkovsky, Herbert L.
    Bengtsson, Leif
    Chandorkar, Gurudatt
    Harding, Matthew
    McNair, Lindsay
    Aalyson, Molly
    Alam, John
    Kauffman, Robert
    Gharakhanian, Shahin
    McHutchison, John G.
    HEPATOLOGY, 2009, 50 (06) : 1719 - 1726
  • [9] Interferon ALFA-2B (IFN-a2B)/ribavirin compared to consensus interferon (CIFN)/ribavirin in treatment of chronic hepatitis C
    Sjogren, MH
    Holtzmuller, K
    Sjogren, RW
    JOURNAL OF HEPATOLOGY, 2001, 34 : 234 - 234
  • [10] Pegylated interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C genotype
    Hasan, F
    Asker, H
    Al-Khaldi, J
    Siddique, I
    Owaid, SF
    Al-Ajmi, M
    Al-Nakib, B
    HEPATOLOGY, 2003, 38 (04) : 629A - 629A
12345